000			02064 a2200541 4500
005			20250513185536.0
264		0	_c19990802
008			199908s 0 0 eng d
022			_a0006-2952
024	7		_a10.1016/s0006-2952(99)00077-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aVrana, J A
245	0	0	_aInhibition of protein kinase C activator-mediated induction of p21CIP1 and p27KIP1 by deoxycytidine analogs in human leukemia cells: relationship to apoptosis and differentiation. _h[electronic resource]
260			_bBiochemical pharmacology _cJul 1999
300			_a121-31 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAntimetabolites, Antineoplastic _xpharmacology
650	0	4	_aApoptosis
650	0	4	_aBryostatins
650	0	4	_aCell Cycle Proteins
650	0	4	_aCell Differentiation _xdrug effects
650	0	4	_aCyclin-Dependent Kinase Inhibitor p21
650	0	4	_aCyclin-Dependent Kinase Inhibitor p27
650	0	4	_aCyclins _xbiosynthesis
650	0	4	_aCytarabine _xpharmacology
650	0	4	_aDeoxycytidine _xanalogs & derivatives
650	0	4	_aDrug Interactions
650	0	4	_aEnzyme Activation
650	0	4	_aHumans
650	0	4	_aLactones _xantagonists & inhibitors
650	0	4	_aLeukemia _xdrug therapy
650	0	4	_aMacrolides
650	0	4	_aMicrotubule-Associated Proteins _xbiosynthesis
650	0	4	_aMitogens _xpharmacology
650	0	4	_aProtein Kinase C _xmetabolism
650	0	4	_aTetradecanoylphorbol Acetate _xantagonists & inhibitors
650	0	4	_aTumor Suppressor Proteins
650	0	4	_aU937 Cells
650	0	4	_aGemcitabine
700	1		_aKramer, L B
700	1		_aSaunders, A M
700	1		_aZhang, X F
700	1		_aDent, P
700	1		_aPovirk, L F
700	1		_aGrant, S
773	0		_tBiochemical pharmacology _gvol. 58 _gno. 1 _gp. 121-31
856	4	0	_uhttps://doi.org/10.1016/s0006-2952(99)00077-5 _zAvailable from publisher's website
999			_c10361754 _d10361754